GHRP-6
Another older-generation GH secretagogue with strong appetite-stimulating activity — largely superseded by Ipamorelin in clinical use.
Definition
GHRP-6 is structurally related to GHRP-2 and shares its basic mechanism — ghrelin-receptor activation producing pulsatile GH release. Its appetite-stimulating effect is more pronounced than GHRP-2 or Hexarelin, which is a reason for its historical use in cachexia but also a reason it's rarely a modern clinical choice.
How Meto uses it.
Not part of Meto's catalogue. The selective secretagogues that followed it don't carry the same appetite effect.
Safety notes
- Pronounced appetite stimulation may be undesirable for most weight-conscious members
- Elevates cortisol and prolactin
- Not a complete list — your clinician reviews your full history, labs and medications during intake
Not a complete list — your clinician reviews your full history, labs and medications during intake. Nothing here replaces that.
Read More
GHRP-2
An older-generation GH secretagogue — active but less selective than Ipamorelin, rarely chosen in modern clinical protocols.
PeptideIpamorelin
A selective growth-hormone secretagogue that triggers GH release without spiking cortisol or prolactin — usually paired with CJC-1295.
PeptideHexarelin
A potent GH secretagogue — more powerful than Ipamorelin but with less selectivity, so less often chosen in modern protocols.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.